Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis
Consistent results across all the analyses support the noninferior efficacy of three all-oral shortened regimens for the treatment of rifampin-resistant tuberculosis. (Funded by Unitaid and others; endTB ClinicalTrials.gov number, NCT02754765.).
Authors
- Nana Kiria (ORCID: https://orcid.org/0000-0002-7449-3296)
- Elisabeth Baudin (ORCID: https://orcid.org/0000-0002-6575-6971)
- S. Toscano
- Payam Nahid (ORCID: https://orcid.org/0000-0003-2811-1311)
- Ohanna Kirakosyan
- Matteo Cellamare
- Maryline Bonnet (ORCID: https://orcid.org/0000-0002-1071-7393)
- Gabriella Ferlazzo
- Uzma Khan (ORCID: https://orcid.org/0000-0002-7706-6572)
- Eduardo Ticona (ORCID: https://orcid.org/0000-0002-6556-1082)
- Sandip Patil (ORCID: https://orcid.org/0000-0003-2736-9206)
- Vijay Chavan (ORCID: https://orcid.org/0000-0003-3563-6896)
- Patrick P. J. Phillips (ORCID: https://orcid.org/0000-0002-6336-7024)
- Vivian Cox (ORCID: https://orcid.org/0000-0002-9730-9068)
- Naseem Salahuddin (ORCID: https://orcid.org/0000-0003-0566-5872)
- Helen McIlleron (ORCID: https://orcid.org/0000-0002-0982-6226)
- Nathalie Lachenal
- Lorenzo Guglielmetti (ORCID: https://orcid.org/0000-0003-0886-9635)
- Lawrence Oyewusi
- Bouke C. de Jong (ORCID: https://orcid.org/0000-0002-1017-4675)
- Carole D. Mitnick (ORCID: https://orcid.org/0000-0002-3455-658X)
- Leonid Lecca (ORCID: https://orcid.org/0000-0003-1363-3985)
- Catherine Berry (ORCID: https://orcid.org/0000-0001-6363-9387)
- Elmira Berikova
- Michael Rich (ORCID: https://orcid.org/0000-0003-4333-4695)
- Gustavo E. Velásquez (ORCID: https://orcid.org/0000-0003-1438-0692)
- Dante Elmo Vargas Vasquez
- Hebah Mushtaque (ORCID: https://orcid.org/0000-0001-9455-0668)
- Samiran Panda (ORCID: https://orcid.org/0000-0002-5077-6275)
- Lorenzo Trippa (ORCID: https://orcid.org/0000-0001-5218-5666)
- Epifanio Sánchez Garavito
- Amanzhan Abubakirov (ORCID: https://orcid.org/0000-0001-6557-9736)
- Francis Varaine
- Ilaria Motta (ORCID: https://orcid.org/0000-0002-3283-3192)
- Sean Wasserman (ORCID: https://orcid.org/0000-0002-3508-6719)
- Zhanna Dakenova
- Aydarkhan Karabayev
- Jimena Ruiz
- Maëlenn Gouillou
- Mikanda Kunda
- Kwonjune J. Seung (ORCID: https://orcid.org/0000-0003-0417-4625)
Institutions
- Inserm (FR)
- Université de Montpellier (FR)
- Sorbonne Université (FR)
- Laboratoire National de Référence (MA)
Publication Details
- Journal
- New England Journal of Medicine
- Published
- 2025-01-29
- DOI
- https://doi.org/10.1056/nejmoa2400327
- Citations
- 60
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 83.77
Funders
- Wellcome Trust
- Fonds Wetenschappelijk Onderzoek
- Vlaamse regering
- National Institute of Allergy and Infectious Diseases